RESPREEZA 5000 mg, powder and solvent for solution for injection/ infusion bottle, 95 ml
Active ingredients: ALPHA-1 ANTITRYPSINE HUMAINE
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injection and infusionbottle, 95 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- RESPREEZA 5000 mg, poudre et solvant pour solution injectable/ perfusion
- Pharmaceutical form
- poudre et solvant pour solution injectable et pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 5000 mg - 1 flacon(s) en verre de 95 ml avec dispositif(s) de transfert 20/20 (dispositif Mix2Vial)
- Marketing authorisation holder
- CSL BEHRING (ALLEMAGNE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Aug 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65543887CIP75505702CIP133400955057024Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ALPHA-1 ANTITRYPSINE HUMAINEpoudre | 5000 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.